Issue of Equity
25 June 2010 - 7:47PM
UK Regulatory
TIDMRGT
For immediate release
25 June 2010
ReGen Therapeutics Plc
Issue of Equity
ReGen Therapeutics Plc ("ReGen" or the "Company"), (AIM:RGT) is pleased to
announce that it has conditionally placed 5,000,000 new ordinary shares at 2p
per ordinary share to raise GBP100,000 before expenses for general working capital
purposes.
The 5,000,000 new ordinary shares, which will represent 7.51 per cent of the
enlarged issued share capital of the Company (in aggregate amounting to
66,613,215 ordinary shares on completion of the placing), will rank pari passu
in all respects with the existing ordinary shares in the Company.
Application has been made to the London Stock Exchange for the new ordinary
shares to be admitted to trading on AIM and admission is expected to commence on
or around Wednesday 30 June 2010.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9820
ENDS
[HUG#1427255]
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: ReGen Therapeutics Plc via Thomson Reuters ONE
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Oct 2023 to Oct 2024